Why Now Daily.

Published

Peripheral Immune Tolerance: How Regulatory T Cells Protect the Body

Peripheral immune tolerance is a set of controls that restrains self-reactive immune cells after they leave central immune organs. Regulatory T cells, whose development depends on FOXP3, are one important part of that protection and were central to the discoveries honored by the 2025 medicine Nobel Prize.

Timeline

  1. 1995: Shimon Sakaguchi reported a distinct class of regulatory T cells that protects against autoimmune disease.
  2. 2001: Mary Brunkow and Fred Ramsdell linked Foxp3 mutations to severe autoimmunity in mice and the human counterpart to IPEX.
  3. 2003: Sakaguchi connected FOXP3 with the development of regulatory T cells.
  4. 2025-10-06: The Nobel Assembly announced the 2025 medicine prize for discoveries concerning peripheral immune tolerance.

Peripheral immune tolerance is the collection of safeguards that restrains immune cells capable of reacting against the body after those cells have reached tissues and circulation. It complements central tolerance, which removes or redirects many self-reactive cells while they mature in organs such as the thymus. Central screening is not perfect, so peripheral controls are essential for preventing damaging responses against healthy tissue. [1][2]

Regulatory T cells, often shortened to Treg cells, are a major part of this control system. The cells monitor and suppress other immune responses, helping the immune system remain capable of fighting infection without routinely attacking the body. The 2025 Nobel Prize in Physiology or Medicine recognized Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for discoveries that established the importance of this form of peripheral tolerance. [1][3]

Sakaguchi’s pivotal 1995 work identified a class of T cells that could protect against autoimmune disease. This challenged the view that tolerance could be explained mainly by deleting dangerous cells in the thymus. Later research characterized the regulatory population through markers including CD4 and CD25 and showed that these cells actively restrain potentially harmful immune reactions in the periphery. [1][2]

Brunkow and Ramsdell helped uncover the genetic link. In 2001, they found that mutations in the mouse Foxp3 gene caused severe autoimmune disease, and mutations in the human counterpart were associated with IPEX, a rare and serious immune-dysregulation syndrome. Sakaguchi subsequently showed that FOXP3 governs the development and function of the regulatory T cells he had identified, connecting the genetic and cellular findings. [1][2][3]

Treg cells are important, but peripheral tolerance is not a single switch. Other mechanisms can make a self-reactive cell unresponsive, delete it, limit the activating signals it receives or regulate it through additional immune-cell interactions. The Nobel scientific background describes co-stimulation, anergy, dendritic-cell behavior and other layers alongside Treg-mediated control. That broader system explains why “peripheral tolerance” should not be treated as another name for only one cell type. [2]

The biology also creates a therapeutic tension. Increasing regulatory control could potentially help in autoimmune disease or transplantation, whereas reducing local suppression might help the immune system attack some cancers. The Nobel materials say these discoveries spurred treatment research and clinical trials, but a biological mechanism or experimental strategy is not proof that a treatment is safe or effective for a particular patient. [1][3]

Peripheral immune tolerance is therefore best understood as active immune regulation outside the main sites of immune-cell development. FOXP3-dependent regulatory T cells provide a central example of how that regulation works, while several other mechanisms contribute. People concerned about autoimmune symptoms or treatment should seek clinical advice; this explainer describes established immunology and Nobel-recognized discoveries rather than offering diagnosis or treatment guidance. [1][2][3]

Sources

  1. Nobel Prize — 2025 medicine prize press release
  2. Nobel Prize — Scientific background on immune tolerance, regulatory T cells and FOXP3
  3. Nobel Prize — Popular science background for the 2025 medicine prize

Related stories